Skip to main content

Table 2 Demographic characteristics and risk factors associated with SCV and NCV presence

From: A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis

 

Valid studies (n)

Total number of patients

SCV Cohort

NCV Cohort

p-value

Age (Mean (SD) of median values)

4

346

16.9 (3.4)

13.0 (5.1)

0.20

Sex, males (n (%))

7

704

104 (44.8)

209 (44.3)

0.89

Prior use of SXTa,b (n (%))

6

449

86 (68.2)

97 (28.5)

< 0.001

  1. aTrimethoprim/sulfamethoxazole
  2. bInvestigation of prior use of SXT is limited to studies of S. aureus